Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 5 papers. Top paper: “Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial”.
Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Nonhlanhla N. Mkhize, Ishana Harkoo +16 more
Nigel Garrett, Disebo Potloane, Izukanji Sikazwe, Edmund V. Capparelli, Ishana Harkoo +22 more
Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Ishana Harkoo, Nonhlanhla Yende‐Zuma +17 more
Elizabeth R. Brown, Craig W. Hendrix, Thesla Palanee‐Phillips, Ariane van der Straten, Ishana Harkoo +8 more
Sharana Mahomed, Aida Sivro, Stéphane Paul, Farzana Osman, Ishana Harkoo +5 more